What a buyer sees
IDEX BIOMETRICS UK LTD
Other engineering activities · Manchester · 09193617
19staff · FY2025
12years trading
—oldest owner on file
—cash at bank
Your turnover is on public record
filed£2.3Mfor the year to 2025
Unusual at this size, and it works in your favour: a buyer is reading your number rather than guessing at one.
What your filings show moving
Staff19
202125 → 192025
Cash at bank£169k
2021£648k → £169k2023
How you sit in your trade
slowest tenth typical fastest tenth youSales per employee£120,611in the bottom quarter
£81,769£150,730£471,809
Debtor daysdays83in the middle half
1566140
Creditor daysdays1
102550
Stock daysdaysnot on your filings
63197
Each spread is companies in the same trade and size that did publish a turnover. Creditor days are shown but not marked: neither end of that one is plainly good.
What a buyer would ask 4
- One director on the registerA buyer's first question about a company run by one person is what happens to it if that person stops. It is usually the first thing priced.
- A director resigned in the past yearA buyer will ask why, and will hear the answer from somewhere. Better from you.
- Headcount fell from 34 to 19A buyer sees the fall and not the reason. Deliberate tightening and losing people look identical on a filing.
- No website on file against the companyThe first thing anyone does with a company number is look for the business behind it. Finding nothing is its own answer.
What a buyer would like 0
Nothing stands out yet from the filings alone.
What the register says
Owners
Nobody recorded with significant control.
Directors
- 52since 2025
| Year to | Filed | Turnover | Staff | Cash |
|---|---|---|---|---|
| 2025-12-31 | 2026-09-11 | £2.3M | 19 | — |
| 2023-12-31 | — | £2.4M | 34 | £169k |
| 2021-12-31 | — | £7.7M | 25 | £648k |
A rough bracket, and why it is only that
0.6–1.5× sales£1.4M£3.4M
The turnover range is fitted on UK companies that did file one. The multiple is a published sector average from Dutch mid-market deals, not from your own numbers and not from your own market. Treat this as the opening bracket of a conversation, not a valuation.